sotera health company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the united states and internationally. its sterilization services include gamma and electron beam irradiation, and eo processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. the company also provides co-60 and gamma irradiators, which are principal components to the gamma sterilization process. its microbiology testing services help customers to identify and measure the potential risks of microbes to a product and ensure that the quality of the products is maintained; and advisory services help customers in navigating the regulatory requirements applicable throughout the product lifecycle. the company was formerly known as sotera health topco, inc. and changed its name to sotera health company in october 2020. sotera health company was incorporated i
Company profile
Ticker
SHC
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Sotera Health Topco, Inc.
SEC CIK
Corporate docs
Subsidiaries
DEROSS Holding B.V. • Nelson Laboratories, LLC • Nelson Laboratories Bozeman, LLC • Nelson Laboratories Fairfield Holdings, LLC • Nelson Laboratories Fairfield, Inc. • Nelson Laboratories Holdings, LLC • Nelson Labs NV • Nordion (Canada) Inc. • Nordion US Holdings LLC • Nordion (US) Inc. ...
IRS number
473531161
SHC stock data
Latest filings (excl ownership)
PRE 14A
Preliminary proxy
22 Mar 24
8-K
Entry into a Material Definitive Agreement
4 Mar 24
424B7
Prospectus with selling stockholder info
29 Feb 24
424B7
Prospectus with selling stockholder info
27 Feb 24
S-3ASR
Automatic shelf registration
27 Feb 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Results of Operations and Financial Condition
27 Feb 24
8-K
Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference
9 Jan 24
8-K
Other Events
21 Dec 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
Transcripts
SHC
Earnings call transcript
2023 Q4
27 Feb 24
SHC
Earnings call transcript
2023 Q3
1 Nov 23
SHC
Earnings call transcript
2023 Q2
3 Aug 23
SHC
Earnings call transcript
2023 Q1
3 May 23
SHC
Earnings call transcript
2023 Q1
3 May 23
SHC
Earnings call transcript
2022 Q4
28 Feb 23
SHC
Earnings call transcript
2022 Q3
2 Nov 22
SHC
Earnings call transcript
2022 Q2
7 Aug 22
SHC
Earnings call transcript
2022 Q1
7 May 22
SHC
Earnings call transcript
2021 Q4
1 Mar 22
Latest ownership filings
4
Change in insider ownership
6 Mar 24
4
Change in insider ownership
6 Mar 24
4
Change in insider ownership
6 Mar 24
4
Jonathan M. Lyons
6 Mar 24
4
ALEXANDER DIMITRIEF
6 Mar 24
4
Ann R. Klee
6 Mar 24
4
Michael P Rutz
5 Mar 24
4
Michael B. Jr. Petras
5 Mar 24
4
Michael P Rutz
22 Nov 23
4
Michael B. Jr. Petras
22 Nov 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 252.53 mm | 252.53 mm | 252.53 mm | 252.53 mm | 252.53 mm | 252.53 mm |
Cash burn (monthly) | 5.99 mm | (no burn) | (no burn) | 17.15 mm | (no burn) | 13.24 mm |
Cash used (since last report) | 35.64 mm | n/a | n/a | 102.14 mm | n/a | 78.86 mm |
Cash remaining | 216.89 mm | n/a | n/a | 150.40 mm | n/a | 173.67 mm |
Runway (months of cash) | 36.2 | n/a | n/a | 8.8 | n/a | 13.1 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 171 |
Opened positions | 20 |
Closed positions | 26 |
Increased positions | 49 |
Reduced positions | 74 |
13F shares | Current |
---|---|
Total value | 3.77 tn |
Total shares | 603.28 mm |
Total puts | 38.10 k |
Total calls | 139.40 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Warburg Pincus & Co. | 175.70 mm | $4.14 bn |
GTCR Investment Xi | 175.70 mm | $4.14 bn |
Warburg Pincus | 105.42 mm | $1.58 tn |
GTCR | 70.28 mm | $1.05 tn |
BLK Blackrock | 9.57 mm | $143.34 bn |
Vanguard | 9.51 mm | $142.51 bn |
JHG Janus Henderson | 8.74 mm | $130.93 bn |
ArrowMark Colorado | 5.85 mm | $87.69 bn |
MIG Capital | 3.44 mm | $51.55 bn |
T. Rowe Price Investment Management | 3.26 mm | $48.88 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 24 | Klee Ann R. | Common Stock, $0.01 par value per share ("Common Stock") | Sell | Dispose S | No | No | 14.3075 | 5,750 | 82.27 k | 86,735 |
4 Mar 24 | Jonathan M. Lyons | Common Stock, $0.01 par value per share ("Common Stock") | Grant | Acquire A | No | No | 0 | 41,124 | 0.00 | 118,091 |
4 Mar 24 | Jonathan M. Lyons | Stock Options Common Stock | Grant | Acquire A | No | No | 14.59 | 81,676 | 1.19 mm | 81,676 |
4 Mar 24 | Alexander Dimitrief | Common Stock, $0.01 par value per share ("Common Stock") | Grant | Acquire A | No | No | 0 | 51,405 | 0.00 | 286,883 |
4 Mar 24 | Alexander Dimitrief | Stock Options Common Stock | Grant | Acquire A | No | No | 14.59 | 102,095 | 1.49 mm | 102,095 |
4 Mar 24 | Rutz Michael P | Common Stock, $0.01 par value per share ("Common Stock") | Sell | Dispose S | No | No | 14.3075 | 83,109 | 1.19 mm | 544,409 |
4 Mar 24 | Rutz Michael P | Common Stock, $0.01 par value per share ("Common Stock") | Grant | Acquire A | No | No | 0 | 34,270 | 0.00 | 627,518 |
4 Mar 24 | Rutz Michael P | Stock Options Common Stock | Grant | Acquire A | No | No | 14.59 | 68,063 | 993.04 k | 68,063 |
4 Mar 24 | Michael B. Jr. Petras | Common Stock, $0.01 par value per share ("Common Stock") | Sell | Dispose S | Yes | No | 14.3075 | 1,003,870 | 14.36 mm | 5,453,580 |
4 Mar 24 | Michael B. Jr. Petras | Common Stock, $0.01 par value per share ("Common Stock") | Grant | Acquire A | No | No | 0 | 274,160 | 0.00 | 699,749 |
News
Jefferies Upgrades Sotera Health to Buy, Raises Price Target to $15.5
25 Mar 24
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
20 Mar 24
10 Health Care Stocks Whale Activity In Today's Session
18 Mar 24
A Glimpse Into The Expert Outlook On Sotera Health Through 4 Analysts
11 Mar 24
RBC Capital Reiterates Outperform on Sotera Health, Maintains $20 Price Target
11 Mar 24
Press releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sotera Health Company - SHC
27 Mar 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sotera Health Company - SHC
25 Mar 24
Sotera Health Announces Pricing of Secondary Offering
28 Feb 24
Sotera Health Announces Secondary Offering of Common Stock
27 Feb 24
Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook
27 Feb 24